Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Accounts Payables (2017 - 2026)

Equillium (EQ) posted quarterly Accounts Payables of $1.3 million for Q1 2026, down 57.65% year-over-year from $3.1 million in Q1 2025, and up 71.52% quarter-over-quarter from $755000.0 in Q4 2025.

Analysis

Equillium (EQ) Accounts Payables (2017 - 2026) Analysis & Trends

Equillium (EQ) has reported Accounts Payables for 10 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accounts Payables fell 57.65% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 57.65% YoY), while the FY2025 annual figure was $755000.0, down 71.79% from the prior year.
  • Accounts Payables advanced to $1.3 million in Q1 2026 per EQ's latest filing, from $755000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $5.7 million in Q1 2023 and bottomed at $755000.0 in Q4 2025.
  • Historically, Accounts Payables has averaged $3.4 million across 5 years, with a median of $3.6 million in 2023.
  • Annual changes were most pronounced in 2022 — Accounts Payables jumped 224.65% — and 2025, when it plunged 71.79%.
  • Equillium's Accounts Payables stood at $4.0 million in 2022, then grew by 18.36% to $4.7 million in 2023, then plunged by 43.15% to $2.7 million in 2024, then slumped by 71.79% to $755000.0 in 2025, then jumped by 71.52% to $1.3 million in 2026.
  • Business Quant data shows EQ's Accounts Payables at $1.3 million in Q1 2026, $755000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Equillium 249.33 Mn 249.33 Mn - 850,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 850,000.00
Mar 31, 2026 1.30 Mn
Dec 31, 2025 755,000.00
Sep 30, 2025 1.08 Mn
Jun 30, 2025 4.81 Mn
Mar 31, 2025 3.06 Mn
Dec 31, 2024 2.68 Mn
Sep 30, 2024 3.67 Mn
Jun 30, 2024 4.49 Mn
Mar 31, 2024 2.78 Mn
Dec 31, 2023 4.71 Mn
Sep 30, 2023 3.64 Mn
Jun 30, 2023 3.03 Mn
Mar 31, 2023 5.69 Mn
Dec 31, 2022 3.98 Mn
Sep 30, 2022 2.47 Mn
Jun 30, 2022 5.09 Mn
Mar 31, 2022 4.21 Mn
Dec 31, 2021 1.23 Mn
Sep 30, 2021 2.67 Mn